03 Aug Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?
In an article published in the BMJ on July 18 Andrew Jack, pharmaceuticals correspondent, Financial Times asks if the heyday of such aggressive marketing of pharmaceuticals (as the one that led to Glaxo being fined...